Authors: Laufman, LR Spiridonidis, CH Pritchard, J Roach, R Zangmeister, J Larrimer, N Moore, T Segal, M Jones, J Patel, T Gutterman, L Carman, L Colborn, D Kuebler, JP

Citation: Lr. Laufman et al., Monthly docetaxel and weekly gemcitabine in metastatic breast cancer: A phase II trial, ANN ONCOL, 12(9), 2001, pp. 1259-1264

Authors: Spiridonidis, CH Laufman, LR Carman, L Moore, T Blair, S Jones, J George, C Patel, T Roach, R Rupert, R Zangmeister, J Colborn, D Kuebler, JP

Citation: Ch. Spiridonidis et al., Second-line chemotherapy for non-small-cell lung cancer with monthly docetaxel and weekly gemcitabine: A phase II trial, ANN ONCOL, 12(1), 2001, pp. 89-94

Authors: Spiridonidis, CH Laufman, LR Jones, JJ Rhodes, VA

Citation: Ch. Spiridonidis et al., Daily times four vinorelbine plus cisplatin in advanced non-small-cell lung cancer: A phase II trial of a novel schedule, ANN ONCOL, 10(8), 1999, pp. 989-991

Authors: Rizvi, NA Spiridonidis, CH Davis, TH Bhargava, P Marshall, JL Dahut, W Figuera, M Hawkins, MJ

Citation: Na. Rizvi et al., Docetaxel and gemcitabine combinations in non-small cell lung cancer, SEMIN ONCOL, 26(5), 1999, pp. 27-31

Authors: Spiridonidis, CH Laufman, LR Jones, J Rhodes, VA Wallace, K Nicol, S

Citation: Ch. Spiridonidis et al., Phase I study of docetaxel dose escalation in combination with fixed weekly gemcitabine in patients with advanced malignancies, J CL ONCOL, 16(12), 1998, pp. 3866-3873